Selection of patients for liver resection

Hepatocellular Carcinoma

Volumn , Issue , 2008, Pages 303-315

  Lai, Eric C H ^a   Lau, W Y ^a   Mann, Darren V ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84988663066     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812770059_0012     Document Type: Chapter

References (53)

1. Lau WY (2000). Primary hepatocellular carcinoma. In: Blumgart LH, Fong Y (eds.), Surgery of the Liver and Biliary Tract, Vol. 2, 2nd ed., WB Saunders, Philadelphia, PA, pp. 1423-50.
2. Lau WY (2000). Primary liver tumors. Semin Surg Oncol 19:135-44.
3. Lau WY (2002). Management of hepatocellular carcinoma. J R Coll Surg Edinb 47:389-99.
4. Lai EC, Lau WY (2005). The continuing challenge of hepatic cancer in Asia. Surgeon 3:210-5.
5. Baron RL, Brancatelli G (2004). Computed tomographic imaging of hepatocellular carcinoma. Gastroenterology 127(Suppl 1):S133-43.
6. Katyal S, Oliver JH 3rd, Peterson MS, et al. (2000). Extrahepatic metastases of hepatocellular carcinoma. Radiology 216:698-703.
7. Uka K, Aikata H, Takaki S, et al. (2007). Clinical features and prognosis of patients with extrahepatic metastases from hepatocellular carcinoma. World J Gastroenterol 13:414-20.
8. Kashiwagi T (2004). FDG-PET and hepatocellular carcinoma. J Gastroenterol 39:1017-8.
9. Verhoef C, Valkema R, de Man RA, et al. (2002). Fluorine-18 FDG imaging in hepatocellular carcinoma using positron coincidence detection and single photon emission computed tomography. Liver 22:51-6.
10. Khan MA, Combs CS, Brunt EM, et al. (2000). Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792-7.
11. Seo S, Hatano E, Higashi T, et al. (2007). Fluorine-18 fluorodeoxyglucose positron emission tomography predicts tumor differentiation, P-glycoprotein expression, and outcome after resection in hepatocellular carcinoma. Clin Cancer Res 13:427-33.
12. Hatano E, Ikai I, Higashi T, et al. (2006). Preoperative positron emission tomography with fluorine-18-fluorodeoxyglucose is predictive of prognosis in patients with hepatocellular carcinoma after resection. World J Surg 30:1736-41.
13. Shiomi S, Nishiguchi S, Ishizu H, etal. (2001). Usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose for predicting outcome in patients with hepatocellular carcinoma. Am J Gastroenterol 96:1877-80.
14. Iwata Y, Shiomi S, Sasaki N, et al. (2000). Clinical usefulness of positron emission tomography with fluorine-18-fluorodeoxyglucose in the diagnosis of liver tumors. AnnNuclMed 14:121-6.
15. Trojan J, Schroeder O, Raedle J, et al. (1999). Fluorine-18 FDG positron emission tomography for imaging of hepatocellular carcinoma. Am J Gastroenterol 94:3314-9.
16. Zhou XD, Tang ZY, Yang BH, et al. (2001). Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer 91:1479-86.
17. Shimozawa N, Hanazaki K (2004). Longterm prognosis after hepatic resection for small hepatocellular carcinoma. J Am Coll Surg 198:356-65.
18. Capussotti L, Muratore A, Amisano M, et al. (2006). Liver resection for large-size hepatocellular carcinomas in 47 non-cirrhotic patients — no mortality and long-term survival. Hepatogastroenterology 53:768-72.
19. Chen XP, Qiu FZ, Wu ZD, et al. (2006). Long-term outcome of resection of large hepatocellular carcinoma. Br J Surg 93:600-6.
20. Pawlik TM, Poon RT, Abdalla EK, et al.; International Cooperative Study Group on Hepatocellular Carcinoma (2005). Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg 140:450-7.
21. Liau KH, Ruo L, Shia J, etal. (2005). Outcome of partial hepatectomy for large (> 10 cm) hepatocellular carcinoma. Cancer 104:1948-55.
22. Nagano Y, Tanaka K, Togo S, et al. (2005). Efficacy of hepatic resection for hepatocellular carcinomas larger than 10 cm. World J Surg 29:66-71.
23. Zhou XD, Tang ZY, Ma ZC, etal. (2003). Surgery for large primary liver cancer more than 10 cm in diameter. J Cancer Res Clin Oncol 129:543-8.
24. Poon RT, Fan ST, Wong J (2002). Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg 194:592-602.
25. Lee NH, Chau GY, Lui WY, et al. (1998). Surgical treatment and outcome in patients with a hepatocellular carcinoma greater than 10 cm in diameter. Br J Surg 85:1654-7.
26. Jeng KS, Chen BF, Lin HJ (1994). En bloc resection for extensive hepatocellular carcinoma: is it advisable? World J Surg 18:834-9.
27. Tung WY, Chau GY, Loong CC, et al. (1996). Surgical resection of primary hepatocellular carcinoma extending to adjacent organ(s). Eur J Surg Oncol 22:516-20.
28. Lau WY, Leung KL, Leung TW, et al. (1995). Resection of hepatocellular carcinoma with diaphragmatic invasion. Br J Surg 82:264-6.
29. Lin MC, Wu CC, Chen JT, etal. (2005). Surgical results of hepatic resection for hepatocellular carcinoma with gross diaphragmatic invasion. Hepatogastroen-terology 52:1497-501.
30. Llovet JM, Fuster J, Bruix J; Barcelona-Clinic Liver Cancer Group (2004). The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl 10(Suppl):S115-20.
31. Ohkubo T, Yamamoto J, Sugawara Y, et al. (2000). Surgical results for hepatocellular carcinoma with macroscopic portal vein tumor thrombosis. J Am Coll Surg 191:657-60.
32. Pawlik TM, Poon RT, Abdalla EK, etal. (2005). Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery 137:403-10.
33. Zhou J, Tang ZY, Wu ZQ, etal. (2006). Factors influencing survival in hepatocellular carcinoma patients with macroscopic portal vein tumor thrombosis after surgery, with special reference to time dependency: a single-center experience of 381 cases. Hepatogastroenterology 53:275-80.
34. Chen XP Huang ZY (2005). Surgical treatment of hepatocellular carcinoma in China: surgical techniques, indications, and outcomes. Langenbecks Arch Surg 390:259-65.
35. Azoulay D, Andreani P, Maggi U, et al. (2006). Combined liver resection and reconstruction of the supra-renal vena cava: the Paul Brousse experience. Ann Surg 244:80-8.
36. Hemming AW, Reed AI, Langham MR Jr., etal. (2004). Combined resection of the liver and inferior vena cava for hepatic malignancy. Ann Surg 239:712-9.
37. Nardo B, Ercolani G, Montalti R, et al. (2005). Hepatic resection for primary or secondary malignancies with involvement of the inferior vena cava: is this operation safe or hazardous? J Am Coll Surg 201:671-9.
38. Lau WY (1997). The history of liver surgery. J R Coll Surg Edinb 42:303-9.
39. Lau WY, Leow CK, Li AKC (1996). Hepatocellular carcinoma— current management and treatment. GI Cancer 2:35-42.
40. Child CG, Turcotte JG (1964). Surgery and portal hypertension. In: Dunphy JE (ed.), The Liver and Portal Hypertension, WB Saunders, Philadelphia, PA, pp. 50-2.
41. Pugh RN, Murray-Lyon IM, Dawson JL, et al. (1973). Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646-9.
42. Wildi S, Pestalozzi BC, McCormack L, Clavien PA (2004). Critical evaluation of the different staging systems for hepatocellular carcinoma. Br J Surg 91:400-8.
43. Makuuchi M, Sano K (2004).The surgical approach to HCC: our progress and results in Japan. Liver Transpl 10(Suppl):S46-52.
44. Bruix J, Castells A, Bosch J, et al. (1996). Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018-22.
45. Redaelli CA, Dufour JF, Wagner M, et al. (2002). Preoperative galactose elimination capacity predicts complications and survival after hepatic resection. Ann Surg 235:77-85.
46. max) is useful for judging the safety of hepatic resection. Surgery 140:379-86.
47. 99mTc—DTPA—galactosyl-human serum albumin dynamic SPECT. J Nucl Med 40:1644-51.
48. Schindl MJ, Redhead DN, Fearon KC, et al.; Edinburgh Liver Surgery and Transplantation Experimental Research Group (eLISTER) (2005). The value of residual liver volume as a predictor of hepatic dysfunction and infection after major liver resection. Gut 54:289-96.
49. Vauthey JN, Chaoui A, Do KA, et al. (2000). Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 127:512-9.
50. Azoulay D, Castaing D, Krissat J, et al. (2000). Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Ann Surg 232:665-72.
51. Tanaka H, Hirohashi K, Kubo S, etal. (2000). Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg 87:879-82.
52. Wakabayashi H, Ishimura K, Okano K, etal. (2001). Is preoperative portal vein embolization effective in improving prognosis after major hepatic resection in patients with advanced-stage hepatocellular carcinoma? Cancer 92:2384-90.
53. Hemming AW, Reed AI, Howard RJ, et al. (2003). Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686-91.